Moreover, because nectin-4 boosts the anchorage-independent growth of epithelial cells26, treatment with rMV-SLAMblind may reduce the number of cancer cells with a malignant phenotype, which drive cancer invasion and metastasis. This evidence concerns the gene NECTIN4 and cancer.